This community workshop hosted by our Equitable Injectable PrEP in LA County Initiative featured a panel of Black and Latino/a cisgender MSM and transgender women (BLMSM/TW) who shared their experiences with injectable PrEP in Los Angeles County.
This policy brief provides lessons learned from the longer-standing experiences of delivering Long Acting Injectables (LAIs) for other chronic conditions in the fields of mental health and addiction offering insights into the use of newly available LAIs for HIV prevention and treatment.
This executive summary highlights lessons learned from the longer-standing experiences of delivering LAIs for other chronic conditions in the fields of mental health and addiction offer insights into the use of newly available LAIs for HIV prevention and treatment. A socio-ecological framework was used to discuss issues surrounding the implementation of LAIs for all three types of conditions and explore ways to maximize potential benefits for HIV.
CHIPTS hosted a community workshop entitled “State of the Science: What we know and what we still need to know about long-acting injectable PrEP” as part of our Equitable Injectable PrEP in LA County Initiative. This workshop occurred on Wednesday, March 8, 2023, from 10:00 AM to 11:30 AM via Zoom, and the primary audience is community members and frontline staff. The workshop was conducted in English with live simultaneous Spanish translation for monolingual Spanish speakers.
The Equitable Injectable PrEP in LA County Initiative presented a workshop with Dr. Raphael J. Landovitz on up-to-date scientific information and clinical considerations for the implementation of long-acting injectable PrEP. The primary audience for this workshop is healthcare providers who serve Black and/or Latina/o transgender women and/or men who have sex with men in Los Angeles County.
The project will host 7 informational/educational community workshops to provide up-to-date and relevant information on LAI-PrEP to providers (medical and non-medical) that serve Black/Latino/a MSM and transgender women and potential consumers. Additionally, the project will develop a community-derived and culturally appropriate strategic messaging guide to facilitate ongoing dissemination of LAI PrEP information to our focused populations of providers and consumers.
Oral presentation by Raphael J. Landovitz at the UCLA HIV Grand Rounds in May 2021. The presentation discussed the HIV Prevention Trials Network (HPTN) 083, a randomized, active-controlled, double-blind clinical trial that began in December 2016. The study has compared the safety and efficacy of two drugs for use as PrEP among a population at increased risk of HIV infection that included MSM ages 18+.
Oral presentation by Oluwadamilola Jolayemi that discusses the LAI treatment study. The presentation discusses the aims of the study that relate to developing partnerships and assessing the barriers of the rollout of LAI ART in Los Angeles County. The presentation also focuses on sharing the qualitative methods of the study and key considerations for implementation based on findings.